Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons

Journal of Neurochemistry

Volumn 83, Issue 2, 2002, Pages 442-451

  Counts, Scott E ^a   McGuire, Susan O ^a   Sortwell, Caryl E ^a   Crawley, Jacqueline N ^b   Collier, Timothy J ^a   Mufson, Elliott J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dopamine; Galanin; Substantia nigra; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

GALANIN; GALANIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; POTASSIUM CHANNEL; TYROSINE 3 MONOOXYGENASE;

ARTICLE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; EMBRYO; ENZYME INHIBITION; FEMALE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BEE VENOMS; BUCLADESINE; CELL COUNT; CELLS, CULTURED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; GALANIN; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; NEURONS; PERTUSSIS TOXIN; RATS; RATS, INBRED F344; RECEPTORS, GALANIN; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 0036796776     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01148.x     Document Type: Article

References (61)

1. Bartfai T., Langel U., Bedecs K., Andell S., Land T., Gregersen S., Ahren B., Girotti P., Consolo S., Corwin R., Crawley J. N., Xu X., Weisenfeld-Hallin Z. and Hokfelt T. (1993) Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc. Natl Acad. Sci. USA 90, 11287-11291.
2. Branchek T. A., Smith K. E., Gerald C. and Walker M. W. (2000) Galanin receptor subtypes. Trends Pharmacol. Sci. 21, 109-117.
3. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
4. Collier T. J. and Sortwell C. E. (1999) Therapeutic potential of nerve growth factors in Parkinson's disease. Drugs Aging 14, 261-287.
5. Consolo S., Uboldi M. C., Caltavuturo C. and Bartfai T (1998) Galanin stimulates the N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in vivo in the rat ventral hippocampus. Neuroscience 85, 819-826.
6. Counts S. E., Perez S. E., Kahl U., Bartfai T., Bowser R. P., Deecher D. C., Mash D. C., Crawley J. N. and Mufson E. J. (2001) Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease. CNS Drug Rev. 7, 445-470.
7. Cragg S. J. and Greenfield S. A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17, 5738-5746.
8. Crawley J. N., Robinson J. K., Langel U. and Bartfai T (1993) Galanin receptor antagonists M40 and C7 block galanin-induced feeding. Brain Res. 600, 268-272.
9. Dascal N. (1997) Signalling via the G protein-activated K+ channels. Cell Signal 9, 551-573.
10. Dutar P., Lamour Y. and Nicoll R. A. (1989) Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur J. Pharmacol. 164, 355-360.
11. Ericson E. and Ahlenius S. (1999) Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Res. 822, 200-209.
12. Fossom L. H., Sterling C. R. and Tank A. W. (1992) Regulation of tyrosine hydroxylase gene transcription rate and tyrosine hydroxylase mRNA stability by cyclic AMP and glucocorticoid. Mol. Pharmacol. 42, 898-908.
13. Gopalan C., Tian Y., Moore K. E. and Lookingland K. J. (1993) Neurochemical evidence that the inhibitory effect of galanin on tuberoinfundibular dopamine neurons is activity dependent. Neuroendocrinology 58, 287-293.
14. Grenhoff J., Nisell M., Ferre S., Aston-Jones G. and Svensson T. H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural. Transm. General Sect. 93, 11-25.
15. Habert-Ortoli E., Amiranoff B., Loquet I., Laburthe M. and Mayaux J. F. (1994) Molecular cloning of a functional human galanin receptor. Proc. Natl Acad. Sci. USA 91, 9780-9793.
16. Heuillet E., Bouaiche Z., Menager J., Dugay P., Munoz N., Dubois H., Amiranoff B., Crespo A., Lavayre J., Blanchard J. C. et al. (1994) The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line. Eur. J. Pharmacol. 269, 139-147.
17. Holets V. R., Hokfelt T., Rokaeus A., Terenius L. and Goldstein M. (1988) Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 24, 893-906.
18. + channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci. 19, 1006-1017.
19. Jin W. and Lu Z. (1998) A novel high-affinity inhibitor for inward-rectifier K+ channels. Biochemistry 37, 13291-11399.
20. Karschin C., Dissmann E., Stuhmer W. and Karschin A. (1996) IRK (1-3) and GIRK (1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. J. Neurosci. 16, 3559-3570.
21. Kim K. S., Lee M. K., Carroll J. and Joh T. H. (1993a) Both the basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element. J. Biol. Chem. 268, 15689-15695.
22. Kim K. S., Park D. H., Wessel T. C., Song B., Wagner J. A. and Joh T. H. (1993b) A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression. Proc. Natl Acad. Sci. USA 90, 3471-3475.
23. Kinney G. A., Emmerson P. J. and Miller R. J. (1998) Galanin receptor-mediated inhibition of glutamate release in the arcuate nucleus of the hypothalamus. J. Neurosci. 18, 3489-3500.
24. Kitamura H., Yokoyama M., Akita H., Matsushita K., Kurachi Y. and Yamada M. (2000) Tertiapin potently and selectively blocks muscarinic K(+) channels in rabbit cardiac myocytes. J. Pharmacol. Exp. Ther. 293, 196-205.
25. Kohler C., Hallman H., Melander T., Hokfelt T. and Norheim E. (1989) Autoradiographic mapping of galanin receptors in the monkey brain. J. Chem. Neuroanat. 2, 269-284.
26. Kolakowski L. F. Jr, O'Neill G. P., Howard A. D., Broussard S. R., Sullivan K. A., Feighner S. D., Sawzdargo M., Nguyen T., Kargman S., Shiao L. L., Hreniuk D. L., Tan C. P., Evans J., Abramovitz M., Chateauneuf A., Coulombe N., Ng G., Johnson M. P., Tharian A., Khoshbouei H., George S. R., Smith R. G. and O'Dowd B. F. (1998) Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J. Neurochem. 71, 2239-2251.
27. Kordower J. H., Le H. K. and Mufson E. J. (1992) Galanin immunoreactivity in the primate central nervous system. J. Comp. Neurol. 319, 479-500.
28. Kumer S. C. and Vrana K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443-462.
29. leviel v., guibert b., Mallet J. and Faucon-Biguet N. (1991) Induction of tyrosine hydroxylase in the rat substantia nigra by local injection of forskolin. J. Neurosci. Res. 30, 427-432.
30. Levitt M., Spector S., Sjoerdsma A. and Udenfriend S. (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis. J. Pharmacol. Exp. Ther 148, 1-7.
31. Liao Y. J., Jan Y. N. and Jan L. Y. (1996) Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J. Neurosci. 16, 7137-7150.
32. Mark M. D. and Herlitze S. (2000) G-protein mediated gating of inwardrectifier K+ channels. Eur. J. Biochem. 267, 5830-5836.
33. McDonald M. P., Gleason T. C., Robinson J. K. and Crawley J. N. (1998) Galanin inhibits performance on rodent memory tasks. Ann. NY Acad. Sci. 863, 305-322.
34. Melander T., Hokfelt T and Rokaeus A. (1986) Distribution of galaninlike immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248, 475-517.
35. Melander T., Fuxe K., Harfstrand A., Eneroth P. and Hokfelt T. (1987) Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat. Possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol. Scand. 131, 25-32.
36. Melander T., Kohler C., Nilsson S., Hokfelt T., Brodin E., Theodorsson E. and Bartfai T. (1988) Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J. Chem. Neuroanat. 1, 213-233.
37. Nordstrom O., Melander T., Hokfelt T., Bartfai T. and Goldstein M. (1987) Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci. Lett. 73, 21-26.
38. O'Donnell D., Ahmad S., Wahlestedt C. and Walker P. (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J. Comp. Neurol. 409, 469-481.
39. Papas S. and Bourque C. W. (1997) Galanin inhibits continuous and phasic firing in rat hypothalamic magnocelllular neurosecretory cells. J. Neurosci. 17, 6048-6056.
40. Parker E. M., Izzarelli D. G., Nowak H. P., Mahle C. D., Iben L. G., Wang J. and Goldstein M. E. (1995) Cloning and characterization of the rat GALR1 galanin receptor from Rinl4B insulinoma cells. Brain Res. Mol. Brain Res. 34, 179-189.
41. Parsons R. L., Mulvaney J. M. and Merriam L. A. (1998) Galanin activates an inwardly rectifying potassium conductance and inhibits a voltage-dependent calcium conductance in mudpuppy parasympathetic neurons. Ann. NYAcad. Sci. 863, 156-169.
42. Perez S. E., Wynick D., Steiner R. A. and Mufson E. J. (2001) Distribution of galaninergic immunoreactivity in the brain of the mouse. J. Comp. Neurol. 434, 158-185.
43. Piech-Dumas K. M., Best J. A., Chen Y., Nagamoto-Combs K., Osterhout C. A. and Tank A. W. (2001) The cAMP responsive element and CREB partially mediate the response of the tyrosine hydroxylase gene to phorbol ester. J. Neurochem. 76, 1376-1385.
44. Pieribone V. A., Xu Z. Q., Zhang X., Grillner S., Bartfai T. and Hokfelt T. (1995) Galanin induces a hyperpolarization of norepinephrinecontaining locus coeruleus neurons in the brainstem slice. Neuroscience 64, 861-874.
45. Skofitsch G. and Jacobowitz D. M. (1985) Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6, 509-546.
46. Skofitsch G., Sills M. A. and Jacobowitz D. M. (1986) Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 7, 1029-1042.
47. Smith K. E., Forray C., Walker M. W., Jones K. A., Tamm J. A., Bard J., Branchek T. A., Linemeyer D. L. and Gerald C. (1997) Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover. J. Biol. Chem. 272, 24612-24616.
48. Smith K. E., Walker M. W., Artymyshyn R., Bard J., Borowsky B., Tamm J. A., Yao W. J., Vaysse P. J., Branchek T. A., Gerald C. and Jones K. A. (1998) Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J. Biol. Chem. 273, 23321-23326.
49. Sortwell C. E., Daley B. F., Pitzer M. R., McGuire S. O., Sladek J. R. Jr and Collier T. J. (2000) Oligodendrocyte-type 2 astrocyte-derived trophic factors increase survival of developing dopamine neurons through the inhibition of apoptotic cell death. J. Comp. Neurol. 426, 143-153.
50. Sullivan K. A., Shiao L. L. and Cascieri M. A. (1997) Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochem. Biophys. Res. Commun. 233, 823-828.
51. Sutin E. L. and Jacobowitz D. M. (1991) Neurochemicals in the dorsal pontine tegmentum. Prog. Brain Res. 88, 3-14.
52. Takeshima T., Shimoda K., Johnston J. M. and Commissiong J. W. (1996) Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J. Neurosci. Methods 67, 27-41.
53. Wang S., Hashemi T., Fried S., Clemmons A. L. and Hawes B. E. (1998) Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-6717.
54. Waters S. M. and Krause J. E. (2000) Distribution of galanin-1-2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 95, 265-271.
55. de Weille J. R., Fosset M., Schmid-Antomarchi H. and Lazdunski M. (1989) Galanin inhibits dopamine secretion and activates a potassium channel in pheochromocytoma cells. Brain Res. 485, 199-203.
56. Weiss J. M., Bonsall R. W., Demetrikopoulos M. K., Emery M. S. and West C. H. (1998) Galanin: a significant role in depression? Ann. NY Acad. Sci. 863, 364-382.
57. Wolf M. E. and Roth R. H. (1990) Autoreceptor regulation of dopamine synthesis. Ann. NY Acad. Sci. 604, 323-343.
58. Wrenn C. C. and Crawley J. N. (2001) Pharmacological evidence supporting a role for galanin in cognition and affect. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 283-299.
59. Xu Z. Q., Zhang X., Pieribone V. A., Grillner S. and Hokfelt T. (1998) Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87, 79-94.
60. Yoshida M., Yokoo H., Tanaka T., Emoto H. and Tanaka M. (1994) Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636, 111-114.
61. Zachariou V., Georgescu D., Kansal L., Merriam P. and Picciotto M. R. (2001) Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism. J. Neurochem. 76, 191-200.